loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Bosutinib Monohydrate Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 5,451Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12Pfizer Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2012-09-04

Application Number : 203341

Regulatory Info : RX

Registration Country : USA

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2012-09-04

Application Number : 203341

Regulatory Info : RX

Registration Country : USA

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE

Packaging :

Approval Date : 2017-10-27

Application Number : 203341

Regulatory Info : RX

Registration Country : USA

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 50MG BASE

Packaging :

Approval Date : 2023-09-26

Application Number : 217729

Regulatory Info : RX

Registration Country : USA

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2023-09-26

Application Number : 217729

Regulatory Info : RX

Registration Country : USA

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

bosutinibmonohydrat

Brand Name : Bosulif

Dosage Form : FILM COATED PILL

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

bosutinibmonohydrat

Brand Name : Bosulif

Dosage Form : FILM COATED PILL

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bosutinib

Brand Name : Bosulif

Dosage Form : Film-Coated Tablets

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bosutinib

Brand Name : Bosulif

Dosage Form : Filmtabl

Dosage Strength : 500mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bosutinib

Brand Name : Bosulif

Dosage Form : Filmtabl

Dosage Strength : 400mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

11

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB (BOSUTINIB MONOHYDRATE)

Brand Name : BOSULIF

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 28/120

Approval Date :

Application Number : 2419149

Regulatory Info : Prescription

Registration Country : Canada

blank

12

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

BOSUTINIB (BOSUTINIB MONOHYDRATE)

Brand Name : BOSULIF

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 28/30

Approval Date :

Application Number : 2419157

Regulatory Info : Prescription

Registration Country : Canada

blank